- Home
- TXMD vs MDRR Comparison
TXMD vs MDRR Comparison
Compare TXMD & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- MDRR
- Stock Information
- Founded
- TXMD 2008
- MDRR 2015
- Country
- TXMD United States
- MDRR United States
- Employees
- TXMD N/A
- MDRR N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- MDRR Real Estate Investment Trusts
- Sector
- TXMD Health Care
- MDRR Real Estate
- Exchange
- TXMD Nasdaq
- MDRR Nasdaq
- Market Cap
- TXMD 12.8M
- MDRR 13.9M
- IPO Year
- TXMD N/A
- MDRR 2018
- Fundamental
- Price
- TXMD $1.30
- MDRR $12.56
- Analyst Decision
- TXMD
- MDRR
- Analyst Count
- TXMD 0
- MDRR 0
- Target Price
- TXMD N/A
- MDRR N/A
- AVG Volume (30 Days)
- TXMD 738.0K
- MDRR 4.9K
- Earning Date
- TXMD 03-28-2025
- MDRR 03-05-2025
- Dividend Yield
- TXMD N/A
- MDRR 1.71%
- EPS Growth
- TXMD N/A
- MDRR N/A
- EPS
- TXMD N/A
- MDRR N/A
- Revenue
- TXMD $1,596,000.00
- MDRR $9,916,929.00
- Revenue This Year
- TXMD $605.07
- MDRR N/A
- Revenue Next Year
- TXMD $1.11
- MDRR N/A
- P/E Ratio
- TXMD N/A
- MDRR N/A
- Revenue Growth
- TXMD N/A
- MDRR N/A
- 52 Week Low
- TXMD $0.70
- MDRR $10.60
- 52 Week High
- TXMD $2.75
- MDRR $15.00
- Technical
- Relative Strength Index (RSI)
- TXMD 68.51
- MDRR 49.84
- Support Level
- TXMD $0.95
- MDRR $12.30
- Resistance Level
- TXMD $1.08
- MDRR $13.31
- Average True Range (ATR)
- TXMD 0.09
- MDRR 0.48
- MACD
- TXMD 0.02
- MDRR 0.06
- Stochastic Oscillator
- TXMD 49.30
- MDRR 27.34
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged in the acquisition, reposition, renovation, leasing, and managing of income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its principal objectives include sourcing value-added Investments in markets in which it maintains deep industry relationships and local market knowledge and the creation of value for stockholders by utilizing its relationships and local knowledge of commercial real estate investment, management, and disposition.